KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to 0.51.

  • Neogenomics' Asset Utilization Ratio rose 3060.32% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year increase of 3060.32%. This contributed to the annual value of 0.4 for FY2024, which is 1508.02% up from last year.
  • As of Q3 2025, Neogenomics' Asset Utilization Ratio stood at 0.51, which was up 3060.32% from 0.46 recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Asset Utilization Ratio registered a high of 0.6 during Q1 2021, and its lowest value of 0.25 during Q3 2021.
  • For the 5-year period, Neogenomics' Asset Utilization Ratio averaged around 0.36, with its median value being 0.34 (2023).
  • In the last 5 years, Neogenomics' Asset Utilization Ratio tumbled by 7145.85% in 2021 and then soared by 3060.32% in 2025.
  • Over the past 5 years, Neogenomics' Asset Utilization Ratio (Quarter) stood at 0.26 in 2021, then increased by 13.69% to 0.29 in 2022, then grew by 20.77% to 0.35 in 2023, then rose by 14.38% to 0.4 in 2024, then increased by 27.15% to 0.51 in 2025.
  • Its Asset Utilization Ratio stands at 0.51 for Q3 2025, versus 0.46 for Q2 2025 and 0.42 for Q1 2025.